Related Experiment Video
Updated: Jul 18, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
Acetylation of the p53 DNA-binding domain regulates apoptosis induction
Stephen M Sykes1, Hestia S Mellert, Marc A Holbert
1Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.
Abstract:
The ability of p53 to induce apoptosis plays an important role in tumor suppression. Here, we describe a previously unknown posttranslational modification of the DNA-binding domain of p53. This modification, acetylation of lysine 120 (K120), occurs rapidly after DNA damage and is catalyzed by the MYST family acetyltransferases hMOF and TIP60. Mutation of K120 to arginine, as occurs in human cancer, debilitates K120 acetylation and diminishes p53-mediated apoptosis without affecting cell-cycle arrest. The K120R mutation selectively blocks the transcription of proapoptotic target genes such as BAX and PUMA while the nonapoptotic targets p21 and hMDM2 remain unaffected. Consistent with this, depletion of hMOF and/or TIP60 inhibits the ability of p53 to activate BAX and PUMA transcription. Furthermore, the acetyllysine 120 (acetyl-K120) form of p53 specifically accumulates at proapoptotic target genes. These data suggest that K120 acetylation may help distinguish the cell-cycle arrest and apoptotic functions of p53.
Insights
p53 acetylation at lysine 120 (K120) is a new posttranslational modification crucial for tumor suppression. This modification, catalyzed by hMOF and TIP60, is vital for p53-mediated apoptosis and distinguishing its functions.
Area of Science:
- Molecular Biology
- Cancer Research
- Cellular Biology
Background:
- The tumor suppressor protein p53 plays a critical role in preventing cancer by inducing apoptosis.
- Posttranslational modifications of p53 significantly influence its diverse cellular functions.
Purpose of the Study:
- To identify and characterize novel posttranslational modifications of p53.
- To investigate the role of p53 acetylation at lysine 120 (K120) in regulating its apoptotic and cell-cycle arrest functions.
Main Methods:
- Site-directed mutagenesis to create K120R p53.
- Western blotting and immunoprecipitation to detect p53 acetylation.
- Quantitative PCR to assess target gene transcription.
- Chromatin immunoprecipitation to determine protein localization.
Main Results:
- Acetylation of p53 at K120, catalyzed by hMOF and TIP60, occurs rapidly after DNA damage.
- The K120R mutation impairs p53-mediated apoptosis by selectively blocking proapoptotic gene transcription (BAX, PUMA) while sparing cell-cycle arrest genes (p21, hMDM2).
- Depletion of hMOF/TIP60 or the K120R mutation prevents the accumulation of acetyl-p53 at proapoptotic gene promoters.
Conclusions:
- K120 acetylation is a critical modification that distinguishes p53's apoptotic and cell-cycle arrest functions.
- This modification is essential for effective tumor suppression by p53.
- Dysregulation of K120 acetylation, as seen in cancer mutations, compromises p53's apoptotic response.
Related Concept Videos
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Negative Regulator Molecules

